17 Nov 2016

Guidelines On Cannabis For Medical Professionals.

In a new initiative, CLEAR's scientific and medical advisor, Professor Mike Barnes, has written to the presidents of several Royal Colleges proposing the development of guidelines around the use of cannabis as medicine. This is a tricky situation for doctors.  Surveys and individual reports from CLEAR members indicate that many doctors tacitly endorse their patients' use of cannabis but clearly cannot recommend the illegal use of cannabis, however safe and effective it may be. Professor Barnes' letter...

09 Nov 2016

CLEAR Statement Concerning Cannabis Legalisation Measures In US Election.

"This is marvellous news for liberty, health and human rights.  The USA, unlike Britain, has a functioning democracy where the will of the people prevails rather than the bigotry and self-interest of politicians.  It is wonderful to see that truth, justice and evidence is winning out over the lies and misinformation we have been fed about cannabis for almost 100 years. In 1971, the British government abdicated all responsibility on cannabis and abandoned our communities and our children to criminal gangs.  Since...

08 Nov 2016

CLEAR Cannabis Law Reform Accounts 2015.

Income Compared to the previous year, CLEAR's regular income in 2015 was up 79% to £17,074. The majority of income continues to come from memberships, with the remainder coming from donations, merchandise and Google advertising. Regular income: £17,074 Expenditure CLEAR spent a total of £12,023, a decrease of 11% on the previous year. Total expenditure: £12,023 Administration: membership administration, stationery, postage, telephone & internet, meeting expenses, etc. Administration costs have increased as an overall proportion of expenditure as there were no dedicated campaigns during the year. Travel:...

04 Nov 2016

Report Of Meeting With MHRA On Regulation of Cannabidiol (CBD).

Yesterday, 3rd November 2016, six delegates from the UK Cannabis Trade Association (UKCTA) met with Medicines and Health Products Regulatory Agency (MHRA) representatives at the agency's headquarters in Victoria. We were courteously received. The meeting was cordial, productive and enabled both sides to clarify their positions and better understand each other's perspective. In...

01 Nov 2016

MHRA Backtracking Super Fast On CBD Ban.

In advance of the meeting between the UK Cannabis Trade Association (UKCTA) and the MHRA on Thursday, there has been a flurry of activity which amounts to a climb down by the regulator. This statement was published on the MHRA website at lunchtime today. "Update 1 November 2016 An MHRA spokesperson said: While MHRA has given its opinion that products containing cannabidiol (CBD) used for medical purposes are medicines, we have also carefully considered the needs of individuals using CBD products to treat or manage the...

30 Oct 2016

UK Cannabis Trade Association Meeting With MHRA This Week.

After all the speculation, many misleading and false reports and a plethora of attempts to interpret the MHRA's actions concerning cannabidiol (CBD), this week the chips are down. On Thursday 3rd November, at MHRA headquarters in Victoria, six representatives of the UK Cannabis Trade Association (UKCTA) will sit down with those responsible for the agency's statements on CBD. We will be armed with counsel's opinion on the legality of the MHRA's action but most importantly we...

19 Oct 2016

MHRA Confirms Meeting With CBD Industry Representatives.

Today, the Medicines and Healthcare products Regulatory Agency (MHRA), has arranged a meeting with representatives from the UK Cannabis Trade Association (UKCTA) to discuss its designation of cannabidiol (CBD) as a medicine. A request for a meeting was was first made in writing on 20th September 2016, when the possibility of the MHRA's action was still little more than a rumour.  Nearly six weeks later, after repeated requests, complaints and lobbying from many companies, individuals and MPs, the meeting has been fixed for 3rd November...

15 Oct 2016

The British Medical Journal (BMJ) Features The CLEAR Medicinal Cannabis Campaign.

"Muddled thinking" over cannabis leaves patients in limbo, warn campaigners BMJ 2016; 355 doi: http://dx.doi.org/10.1136/bmj.i5556 (Published 14 October 2016) Cite this as: BMJ 2016;355:i5556 Download PDF here Companies selling cannabis based products have been told to remove them from the market within 28 days, after a review by the Medicines and Healthcare Products Regulatory Agency (MHRA) determined that they were medicinal products. Campaigners for cannabis law reform welcomed the recognition that cannabidiol (CBD) had medicinal properties but warned that...

12 Oct 2016

The Man From The MHRA. Endangering Public Health With Precipitate Action On CBD.

The Medicines and Healthcare Products Regulatory Agency (MHRA) apparent decision to designate cannabidiol (CBD) as a medicine is an unholy mess and has been handled about as badly as it is possible for a government agency to deal with a matter of public safety. The desk of Dr Ian Hudson, the Chief Executive, will shortly be groaning under the weight of correspondence from MPs asking him to explain exactly what is going on.  We know that...